WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) released the following statement regarding today’s U.S. Department of Health and Human Services’ (HHS) Forum on Pharmaceutical Innovation, Access, Affordability and Better Health:
“Ensuring that patients have access to the treatments and therapies they need is one of the most important issues we face today. At BIO, we welcome the opportunity to have a robust dialogue with all of the stakeholders in the health care system about what is needed to make sure that patients have access to our innovations and how we can speed the development of the next generation of cures and therapies, so that more patients can benefit from these breakthroughs.
“Ensuring that patients have access to the treatments and therapies they need is one of the most important issues we face today. At BIO, we welcome the opportunity to have a robust dialogue with all of the stakeholders in the health care system about what is needed to make sure that patients have access to our innovations and how we can speed the development of the next generation of cures and therapies, so that more patients can benefit from these breakthroughs.
